Oruka Therapeutics, Inc. Quarterly Other Assets, Current in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Oruka Therapeutics, Inc. quarterly Other Assets, Current history and growth rate from Q4 2010 to Q2 2024.
  • Oruka Therapeutics, Inc. Other Assets, Current for the quarter ending June 30, 2024 was $537K, a 10.4% decline year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $537K -$62K -10.4% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $767K -$85K -9.98% Mar 31, 2024 10-Q 2024-04-25
Q4 2023 $161K -$93K -36.6% Dec 31, 2023 10-Q 2024-08-01
Q3 2023 $405K -$206K -33.7% Sep 30, 2023 10-Q 2023-10-18
Q2 2023 $599K -$619K -50.8% Jun 30, 2023 10-Q 2023-07-21
Q1 2023 $852K -$628K -42.4% Mar 31, 2023 10-Q 2023-04-24
Q4 2022 $254K -$808K -76.1% Dec 31, 2022 10-K 2024-02-01
Q3 2022 $611K -$742K -54.8% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 $1.22M -$378K -23.7% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $1.48M -$317K -17.6% Mar 31, 2022 10-Q 2022-05-02
Q4 2021 $1.06M +$165K +18.4% Dec 31, 2021 10-K 2023-02-24
Q3 2021 $1.35M +$512K +60.9% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $1.6M +$1.06M +200% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $1.8M +$1.09M +155% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $897K +$780K +667% Dec 31, 2020 10-K 2022-03-14
Q3 2020 $841K +$582K +225% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 $532K +$175K +49% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $704K +$191K +37.2% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $117K -$52K -30.8% Dec 31, 2019 10-K 2021-03-18
Q3 2019 $259K -$77K -22.9% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $357K -$18K -4.8% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $513K -$118K -18.7% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $169K -$378K -69.1% Dec 31, 2018 10-K 2020-02-18
Q3 2018 $336K -$89K -20.9% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 $375K -$273K -42.1% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $631K -$12K -1.87% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $547K +$265K +94% Dec 31, 2017 10-K 2019-02-27
Q3 2017 $425K +$105K +32.8% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $648K +$271K +71.9% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 $643K +$252K +64.5% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 $282K +$168K +147% Dec 31, 2016 10-K 2018-03-22
Q3 2016 $320K +$115K +56.1% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 $377K +$136K +56.4% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $391K -$99K -20.2% Mar 31, 2016 10-Q 2016-05-11
Q4 2015 $114K -$20K -14.9% Dec 31, 2015 10-K 2017-03-21
Q3 2015 $205K -$11K -5.09% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 $241K -$62K -20.5% Jun 30, 2015 10-Q 2015-08-11
Q1 2015 $490K -$109K -18.2% Mar 31, 2015 10-Q 2015-05-12
Q4 2014 $134K -$35K -20.7% Dec 31, 2014 10-K 2016-03-17
Q3 2014 $216K -$163K -43% Sep 30, 2014 10-Q 2014-11-12
Q2 2014 $303K +$19K +6.69% Jun 30, 2014 10-Q 2014-08-13
Q1 2014 $599K +$143K +31.4% Mar 31, 2014 10-Q 2014-05-13
Q4 2013 $169K +$44K +35.2% Dec 31, 2013 10-K 2015-03-19
Q3 2013 $379K +$195K +106% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 $284K -$124K -30.4% Jun 30, 2013 10-Q 2013-08-13
Q1 2013 $456K -$19K -4% Mar 31, 2013 10-Q 2013-05-13
Q4 2012 $125K -$144K -53.5% Dec 31, 2012 10-K 2014-03-20
Q3 2012 $184K -$156K -45.9% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 $408K +$44K +12.1% Jun 30, 2012 10-Q 2012-08-13
Q1 2012 $475K Mar 31, 2012 10-Q 2012-05-14
Q4 2011 $269K +$132K +96.4% Dec 31, 2011 10-K 2013-03-21
Q3 2011 $340K Sep 30, 2011 10-Q 2011-11-14
Q2 2011 $364K Jun 30, 2011 10-Q 2011-08-15
Q4 2010 $137K Dec 31, 2010 10-K 2012-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.